Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
2,664
-3
-0.1% -$351 0.09% 66
2026
Q1
$321K Buy
2,667
+17
+0.6% +$1.96K 0.1% 62
2025
Q4
$279K Buy
2,650
+52
+2% +$4.88K 0.09% 70
2025
Q3
$218K Buy
2,598
+6
+0.2% +$494 0.07% 85
2025
Q2
$205K Sell
2,592
-102
-4% -$8.11K 0.07% 91
2025
Q1
$242K Sell
2,694
-133
-5% -$12.4K 0.09% 71
2024
Q4
$281K Sell
2,827
-189
-6% -$19.5K 0.11% 65
2024
Q3
$342K Sell
3,016
-12
-0.4% -$1.43K 0.13% 58
2024
Q2
$375K Sell
3,028
-54
-2% -$6.96K 0.15% 64
2024
Q1
$407K Buy
3,082
+14
+0.5% +$1.73K 0.17% 62
2023
Q4
$334K Sell
3,068
-51
-2% -$5.29K 0.15% 68
2023
Q3
$321K Sell
3,119
-32
-1% -$3.45K 0.16% 66
2023
Q2
$364K Buy
3,151
+99
+3% +$11.2K 0.17% 62
2023
Q1
$325K Buy
3,052
+509
+20% +$55K 0.17% 58
2022
Q4
$282K Sell
2,543
-51
-2% -$5.21K 0.17% 55
2022
Q3
$223K Sell
2,594
-97
-4% -$8.66K 0.14% 59
2022
Q2
$245K Sell
2,691
-139
-5% -$12.3K 0.15% 59
2022
Q1
$232K Buy
+2,830
New +$223K 0.13% 70

Other funds holding MRK

Veery Capital's MRK Position: Q2 2026 in Review

Veery Capital reduced its Merck (MRK) stake by 0.11% in Q2 2026, selling an estimated $351 and leaving 2,664 shares worth $342K. The position accounts for 0.09% of the portfolio, ranked #66.

Veery Capital first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. The position peaked at $407K in Q1 2024. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Veery Capital held 2,664 shares of Merck worth $342K as of Q2 2026.
  • Veery Capital sold 3 Merck shares in Q2 2026, an estimated $351.
  • Merck made up 0.09% of Veery Capital's portfolio in Q2 2026, its #66 holding.
  • Veery Capital first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • Veery Capital's Merck position peaked at $407K in Q1 2024.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.